Interchange Capital Partners’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $468K | Sell |
1,052
-36
| -3% | -$16K | 0.11% | 159 |
|
|
2025
Q1 | $527K | Buy |
1,088
+52
| +5% | +$25.2K | 0.15% | 134 |
|
|
2024
Q4 | $418K | Sell |
1,036
-464
| -31% | -$187K | 0.15% | 148 |
|
|
2024
Q3 | $698K | Buy |
1,500
+107
| +8% | +$49.8K | 0.25% | 105 |
|
|
2024
Q2 | $653K | Buy |
1,393
+581
| +72% | +$272K | 0.24% | 108 |
|
|
2024
Q1 | $359K | Buy |
+812
| New | +$359K | 0.24% | 98 |
|
|
2023
Q4 | – | Sell |
-916
| Closed | -$318K | – | 162 |
|
|
2023
Q3 | $318K | Buy |
+916
| New | +$318K | 0.25% | 97 |
|
|
2021
Q1 | – | Sell |
-331
| Closed | -$78K | – | 1070 |
|
|
2020
Q4 | $78K | Buy |
+331
| New | +$78K | 0.04% | 338 |
|